Morphine sulfate 30 MG Extended Release Oral Tablet — RxCUI 891888
RxNorm drug concept · Semantic clinical drug
RxCUI 891888
Semantic clinical drug · SCD
● Current RxNorm concept 34 FDA products
74 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI891888
Official nameMorphine sulfate 30 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asMS 30 MG Extended Release Oral Tablet
FDA products mapped34
Package NDCs mapped74
Reported Medicaid activity (SDUD)216,946 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Morphine Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Morphine injection is used to relieve severe pain — the kind that hasn't responded well enough to other treatments. It's not used for mild or moderate pain. Depending on the produc...
- What is morphine injection actually used for?
- When morphine is given near your spinal cord — either in the epidural space or directly into the spinal fluid — it can cause your breathing to slow down dangerously, even hours aft...
- Why do I have to be watched so closely after getting the epidural or spinal version?
🕸️ Concept Web — How Morphine sulfate 30 MG Extended Release Oral Tab... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Morphine sulfate 30 MG Extended Release Oral Tablet
RxCUI 891888 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Morphine
7052IN -
Morphine sulfate
30236PIN
-
Morphine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
MS Contin
203354BN
-
MS Contin
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Morphine Extended Release Oral Tablet
372960SCDF -
Morphine sulfate Extended Release Oral Tablet
2645326SCDFP -
Morphine Oral Product
1156363SCDG -
Morphine Pill
1156364SCDG -
Morphine sulfate Oral Product
2661613SCDGP -
Morphine sulfate Pill
2661827SCDGP -
Morphine Extended Release Oral Tablet [MS Contin]
369896SBDF -
Morphine sulfate Extended Release Oral Tablet [MS Contin]
2656258SBDFP - +5 more in this family
-
Morphine Extended Release Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Morphine sulfate 30 MG
859963SCDC -
Morphine sulfate 30 MG Extended Release Oral Tablet [MS Contin]
892660SBD -
Morphine sulfate 30 MG [MS Contin]
892659SBDC
-
Morphine sulfate 30 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Morphine sulfate 30 MG
SCDC · 859963 -
Morphine Extended Release Oral Tablet
SCDF · 372960 -
Morphine sulfate Extended Release Oral Tablet
SCDFP · 2645326 -
Morphine Oral Product
SCDG · 1156363 -
Morphine Pill
SCDG · 1156364 -
Morphine sulfate Oral Product
SCDGP · 2661613 -
Morphine sulfate Pill
SCDGP · 2661827
Brand-Name Concepts
-
Morphine sulfate 30 MG Extended Release Oral Tablet [MS Contin]
SBD · 892660 -
Morphine sulfate 30 MG [MS Contin]
SBDC · 892659 -
Morphine Extended Release Oral Tablet [MS Contin]
SBDF · 369896 -
Morphine sulfate Extended Release Oral Tablet [MS Contin]
SBDFP · 2656258 -
MS Contin Oral Product
SBDG · 1184943 -
MS Contin Pill
SBDG · 1184944 -
MS Contin
BN · 203354
📦 FDA Products & Package NDCs
34 products · 74 package NDCs
74 package NDCs map to RxCUI 891888 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00228-4271-11 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0228-... | Morphine sulfate | Actavis Pharma, Inc. | 2015-10-26 |
| 00406-8315-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0406-8315-01) | MORPHINE SULFATE | SpecGx LLC | 2003-07-31 |
| 00406-8315-23 | 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8315-23) | MORPHINE SULFATE | SpecGx LLC | 2003-07-31 |
| 00406-8315-62 | 100 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8315-62... | MORPHINE SULFATE | SpecGx LLC | 2003-07-31 |
| 00406-8320-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0406-8320-01) | MORPHINE SULFATE | SpecGx LLC | 2003-07-03 |
| 00406-8330-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0406-8330-01) | MORPHINE SULFATE | SpecGx LLC | 2003-07-31 |
| 00406-8330-23 | 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8330-23) | MORPHINE SULFATE | SpecGx LLC | 2003-07-31 |
| 00406-8330-62 | 100 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8330-62... | MORPHINE SULFATE | SpecGx LLC | 2003-07-31 |
| 00406-8380-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0406-8380-01) | MORPHINE SULFATE | SpecGx LLC | 2003-07-31 |
| 00406-8380-23 | 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8380-23) | MORPHINE SULFATE | SpecGx LLC | 2003-07-31 |
| 00406-8380-62 | 100 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8380-62... | MORPHINE SULFATE | SpecGx LLC | 2003-07-31 |
| 00406-8390-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0406-8390-01) | MORPHINE SULFATE | SpecGx LLC | 2003-07-03 |
| 00406-8390-23 | 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8390-23) | MORPHINE SULFATE | SpecGx LLC | 2003-07-03 |
| 00406-8390-62 | 100 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0406-8390-62... | MORPHINE SULFATE | SpecGx LLC | 2003-07-03 |
| 00904-6557-61 | 100 BLISTER PACK in 1 CARTON (0904-6557-61) / 1 TABLET, FIL... | Morphine Sulfate Extended Release | Major Pharmaceuticals | 2011-01-14 |
| 00904-6558-61 | 100 BLISTER PACK in 1 CARTON (0904-6558-61) / 1 TABLET, FIL... | Morphine Sulfate Extended Release | Major Pharmaceuticals | 2011-01-14 |
| 00904-6559-61 | 100 BLISTER PACK in 1 CARTON (0904-6559-61) / 1 TABLET, FIL... | Morphine Sulfate Extended Release | Major Pharmaceuticals | 2011-01-14 |
| 00904-6560-61 | 100 BLISTER PACK in 1 CARTON (0904-6560-61) / 1 TABLET, FIL... | Morphine Sulfate Extended Release | Major Pharmaceuticals | 2011-01-14 |
| 42858-0515-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... | MS Contin | Rhodes Pharmaceuticals LLC | 2017-05-15 |
| 42858-0631-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... | MS Contin | Rhodes Pharmaceuticals LLC | 2017-05-15 |
| 42858-0760-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... | MS Contin | Rhodes Pharmaceuticals LLC | 2017-05-15 |
| 42858-0801-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... | Morphine Sulfate Extended Release | Rhodes Pharmaceuticals LLC | 2011-01-14 |
| 42858-0802-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... | Morphine Sulfate Extended Release | Rhodes Pharmaceuticals LLC | 2011-01-14 |
| 42858-0803-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... | Morphine Sulfate Extended Release | Rhodes Pharmaceuticals LLC | 2011-01-14 |
| 42858-0804-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... | Morphine Sulfate Extended Release | Rhodes Pharmaceuticals LLC | 2011-01-14 |
| 42858-0805-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... | Morphine Sulfate Extended Release | Rhodes Pharmaceuticals LLC | 2011-01-14 |
| 43386-0540-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43386... | Morphine Sulfate | Lupin Pharmaceuticals,Inc. | 2015-12-16 |
| 43386-0541-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43386... | Morphine Sulfate | Lupin Pharmaceuticals,Inc. | 2015-12-16 |
| 43386-0542-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43386... | Morphine Sulfate | Lupin Pharmaceuticals,Inc. | 2015-12-16 |
| 43386-0543-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43386... | Morphine Sulfate | Lupin Pharmaceuticals,Inc. | 2015-12-16 |
| 43386-0544-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (43386... | Morphine Sulfate | Lupin Pharmaceuticals,Inc. | 2015-12-16 |
| 63304-0450-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304... | Morphine sulfate | Sun Pharmaceutical Industries, Inc. | 2012-05-11 |
| 63304-0450-03 | 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-... | Morphine sulfate | Sun Pharmaceutical Industries, Inc. | 2012-05-11 |
| 63304-0450-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304... | Morphine sulfate | Sun Pharmaceutical Industries, Inc. | 2012-05-11 |
| 63304-0451-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304... | Morphine sulfate | Sun Pharmaceutical Industries, Inc. | 2012-05-11 |
| 63304-0451-03 | 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-... | Morphine sulfate | Sun Pharmaceutical Industries, Inc. | 2012-05-11 |
| 63304-0451-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304... | Morphine sulfate | Sun Pharmaceutical Industries, Inc. | 2012-05-11 |
| 63304-0452-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304... | Morphine sulfate | Sun Pharmaceutical Industries, Inc. | 2012-05-11 |
| 63304-0452-03 | 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-... | Morphine sulfate | Sun Pharmaceutical Industries, Inc. | 2012-05-11 |
| 63304-0452-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304... | Morphine sulfate | Sun Pharmaceutical Industries, Inc. | 2012-05-11 |
| 63304-0453-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304... | Morphine sulfate | Sun Pharmaceutical Industries, Inc. | 2012-05-11 |
| 63304-0453-03 | 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-... | Morphine sulfate | Sun Pharmaceutical Industries, Inc. | 2012-05-11 |
| 63304-0453-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304... | Morphine sulfate | Sun Pharmaceutical Industries, Inc. | 2012-05-11 |
| 63304-0758-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304... | Morphine sulfate | Sun Pharmaceutical Industries, Inc. | 2012-05-11 |
| 63304-0758-03 | 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-... | Morphine sulfate | Sun Pharmaceutical Industries, Inc. | 2012-05-11 |
| 63304-0758-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304... | Morphine sulfate | Sun Pharmaceutical Industries, Inc. | 2012-05-11 |
| 63304-0758-50 | 50 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63304-... | Morphine sulfate | Sun Pharmaceutical Industries, Inc. | 2012-05-11 |
| 63629-1088-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629... | Morphine sulfate | Bryant Ranch Prepack | 2022-04-26 |
| 63629-4484-00 | 40 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-... | Morphine Sulfate | Bryant Ranch Prepack | 2021-12-22 |
| 63629-4484-01 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-... | Morphine Sulfate | Bryant Ranch Prepack | 2011-04-18 |
Observed labelers:
Bryant Ranch Prepack (25) ·
Sun Pharmaceutical Industries, Inc. (16) ·
SpecGx LLC (13) ·
Rhodes Pharmaceuticals LLC (8) ·
Lupin Pharmaceuticals,Inc. (5) ·
Major Pharmaceuticals (4)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.